Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Injection of Adipose-derived Regenerative Cells (ADRCs) in Patients Suffering From Osteoarthritis of the Facet Joints

NCT03513731 is registered in ClinicalTrials.gov with InGeneron, Inc. as lead sponsor.

NCT NCT03513731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03513731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Injection of Adipose-derived Regenerative Cells (ADRCs) in Patients Suffering From Osteoarthritis of the Facet Joints
Lead sponsor
InGeneron, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
December 7, 2018
Completion date
April 30, 2026
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of facet joint of lumbar spine